These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 5038526

  • 1. [Tolerance and effectiveness of Cormelian in patients with coronary disease].
    Messerich J.
    Med Welt; 1972 Apr 08; 23(15):563-6. PubMed ID: 5038526
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Report on the clinical testing of Cormelian-Digotab].
    Pollter J.
    Med Welt; 1974 Nov 29; 25(48):2015-21. PubMed ID: 4617836
    [No Abstract] [Full Text] [Related]

  • 4. [Cormelian (Dilazep) a new coronary active substance].
    Reuter H.
    Z Allgemeinmed; 1974 Oct 10; 50(28):1255-6. PubMed ID: 4614598
    [No Abstract] [Full Text] [Related]

  • 5. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease].
    Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H.
    Arzneimittelforschung; 1974 Nov 10; 24(11A Suppl):1853-64. PubMed ID: 4480270
    [No Abstract] [Full Text] [Related]

  • 6. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H.
    Arzneimittelforschung; 1974 Nov 10; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract] [Full Text] [Related]

  • 7. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy].
    Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H.
    Arzneimittelforschung; 1974 Nov 10; 24(11A Suppl):1864-72. PubMed ID: 4615714
    [No Abstract] [Full Text] [Related]

  • 8. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis].
    Schneider VB, Feldmann U, von Brachel H, Schnitker J, Gelbhaar H.
    Arzneimittelforschung; 1974 Nov 10; 24(11A Suppl):1879-93. PubMed ID: 4155951
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of therapy-resistant stenocardias associated with myocardial insufficiency using cormelian-digotab in a rehabilitation clinic].
    Koeffler H.
    Fortschr Med; 1974 Dec 19; 92(35-36):1458-61. PubMed ID: 4435699
    [No Abstract] [Full Text] [Related]

  • 10. [Efficiency of Cormelian in coronary insufficiency. Results of a double-blind study].
    Gillner H, Pollter J, Schnitker J, Sievers HG, Zylmann G.
    Med Monatsschr; 1975 Feb 19; 29(2):82-7. PubMed ID: 1092990
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of hexobendin in coronary diseases].
    Varela de Seijas y Agui, González Peña JJ, González García L.
    Rev Clin Esp; 1968 Apr 30; 109(2):147-52. PubMed ID: 5741634
    [No Abstract] [Full Text] [Related]

  • 12. [Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians].
    Pollter J, Schnitker J.
    Med Welt; 1975 Oct 31; 26(44):2007-12. PubMed ID: 1186488
    [No Abstract] [Full Text] [Related]

  • 13. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L, Wnukowska M, Dmoszyńska A.
    World Health Organ Tech Rep Ser; 1974 Mar 01; 27(5):463-6. PubMed ID: 4206990
    [No Abstract] [Full Text] [Related]

  • 14. [Results of the clinical testing of a new coronary drug, Cormelian].
    Pollter J.
    Fortschr Med; 1972 Apr 06; 90(10):399-404. PubMed ID: 4616888
    [No Abstract] [Full Text] [Related]

  • 15. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L, Wnukowska M, Dmoszyńska A.
    Wiad Lek; 1974 Mar 01; 27(5):463-6. PubMed ID: 4603373
    [No Abstract] [Full Text] [Related]

  • 16. [New treatment in coronary insufficiency: perhexiline maleate].
    Fayard JM, Gay J, Ourbak P, Queste M, Maurice P.
    Nouv Presse Med; 1973 Jun 09; 2(23):1583-4. PubMed ID: 4713406
    [No Abstract] [Full Text] [Related]

  • 17. [Analysis of the vasoactive effects of hexobendin].
    Zhmurkin VP, Troshina TF.
    Ter Arkh; 1973 Jan 09; 45(1):73-9. PubMed ID: 4770026
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical assessment of certain preparations used in coronary insufficiency].
    Votchal BE, Gol'dberg VA.
    Klin Med (Mosk); 1970 Feb 09; 48(2):48-53. PubMed ID: 5425982
    [No Abstract] [Full Text] [Related]

  • 19. [Use of cloridarol in coronary insufficiency].
    Mossuti E, Nigro P, Diene G, Petralito A.
    Minerva Med; 1976 Apr 30; 67(21):1394-7. PubMed ID: 934497
    [Abstract] [Full Text] [Related]

  • 20. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].
    Baldrighi V, Barbaresi F, Plancher AC, Portioli I.
    Clin Ter; 1976 Aug 31; 78(4):303-62. PubMed ID: 795597
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.